Put companies on watchlist
H&R GmbH & Co. KGaA
ISIN: DE000A2E4T77
WKN: A2E4T7
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

H&R GmbH & Co. KGaA · ISIN: DE000A2E4T77 · EQS - Company News (64 News)
Country: Germany · Primary market: Germany · EQS NID: 1316695
31 March 2022 10:13AM

H&R GmbH & Co. KGaA publishes Annual Report 2021


DGAP-News: H&R GmbH & Co. KGaA / Key word(s): Annual Results/Annual Report
H&R GmbH & Co. KGaA publishes Annual Report 2021

31.03.2022 / 10:13
The issuer is solely responsible for the content of this announcement.


H&R GmbH & Co. KGaA publishes Annual Report 2021

- H&R slightly exceeds preliminary figures and ends financial year 2021 with record EBITDA of EUR 132.5 million.

 

Salzbergen, March 31, 2022. H&R GmbH & Co. KGaA (H&R KGaA; ISIN DE000A2E4T77) reported an operating result (EBITDA - consolidated earnings before taxes on income and earnings, other financing income and expenses as well as depreciation, impairments and write-ups on intangible assets and property, plant and equipment) for the 2021 financial year of EUR 132.5 million (2020: EUR 55.8 million) (for the other earnings levels, see table "Key figures" below). The bottom line is that the consolidated result attributable to shareholders amounted to EUR 50.2 million (2020: EUR -9.0 million). The result was achieved with sales of EUR 1,188.4 million. This was EUR 315.4 million more than in the previous year (2020: EUR 873.0 million) due to price and volume reasons.

Key Figures for H&R KGaA:

in € million 2021 2020 - / +
       
Sales revenues 1,188.4 873.0 315.4
Operative Earnings (EBITDA) 132.5 55.8 76.7
in % of Sales Revenues 11.1 6.4 4.7
EBIT 81.6 -0.3 81,9
Earnings before Income Taxes 73.4 -10.4 83.8
Earnings after Taxes 52.5 -7.8 60.3
Net Profit attributable to Shareholders 50.2 -9.0 59.2
Earnings per Share (€) 1.35 -0.24 1.59
Operating Cash flow 37.4 60.1 -22.7
       
  31/12/21 31/12/20 - / +
Balance Sheet Total 874.4 745.7 128.7
Equity 408.5 346.9 61.6
Equity Ratio (in%) 46.7 46.5 0.2
Employees (absolut) 1,585 1,585 0
 

Key Figures for segments

in Mio. € 2021 2020 - / +
       
Sales revenues      
ChemPharm Refining 745.3 524.6 220.7
ChemPharm Sales 412.2 317.0 95.2
Plastics 43.8 40.1 3.7
Reconciliation -12.8 -8.7 -4.1
       
EBITDA      
ChemPharm Refining 103.4 35.2 68.2
ChemPharm Sales 29.0 25.9 3.1
Plastics 3.9 -0.4 4.3
Reconciliation -3.8 -4.9 1.1
 

No dividend proposal to the Annual General Meeting
In principle, H&R has achieved a distributable result according to HGB for 2021. Nevertheless, the company's management will propose to the annual general meeting that no dividend be paid. First and foremost, this is due to the existing financial resources of the KfW Entrepreneur Loan and its conditions, which exclude a distribution until full repayment. The payment of a minimum dividend would not be affected by this, however, given the current development in Ukraine and the finally unforeseeable consequences for the German economy, the company does not consider such an outflow of funds to be appropriate. Although H&R has come through the crisis relatively well so far, the persistently uncertain economic prospects for Germany as a business location and for many of our customer industries speak in favor of keeping the funds in the company.

Outlook
We are currently formulating our expectations for 2022 with an operating result (EBITDA) in the range of €80.0 million to €95.0 million. For a complete presentation of the business development including segment reporting and the annual financial statements, H&R KGaA refers to today Annual Report 2021 published at www.hur.com - Investor Relations - Publications Overview.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Tel.: +49 40 43218-321, Fax: +49 40 43218-390
e-mail: ties.kaiser@hur.com ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.



31.03.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: investor.relations@hur.com
Internet: www.hur.com
ISIN: DE000A2E4T77
WKN: A2E4T7
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1316695

 
End of News DGAP News Service

1316695  31.03.2022 

fncls.ssp?fn=show_t_gif&application_id=1316695&application_name=news&site_id=boersengefluester_html
Visual performance / price development - H&R GmbH & Co. KGaA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.